Allergy Therapeutics Plc has appointed Thomas Lander, an independent strategic consultant, as a non-executive director. Dr Lander will replace Virinder Nohria who will retire from the board on 30 June. Dr Lander has more than 25 years of experience in the biopharmaceutical industry which includes senior management positions at Boehringer Ingelheim, Novo Nordisk and Bristol-Myers Squibb.
Allergy Therapeutics announced the appointment on 2 May 2012.
Copyright 2011 Evernow Publishing Ltd